# China NMPA Drug Inspection - Henan Baiyuankang Pharmaceutical Co., Ltd. - Stir-fried jujube seeds

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/henan-baiyuankang-pharmaceutical-co-ltd/c87ef6e9-080e-4217-817e-5628fc1e8a7c/
Source feed: China

> China NMPA drug inspection for Henan Baiyuankang Pharmaceutical Co., Ltd. published December 06, 2017. Drug: Stir-fried jujube seeds. On December 6, 2017, the Henan Provincial Food and Drug Administration announced findings from recent drug quality asses

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Henan Provincial Food and Drug Administration Regarding 5 Batches of Substandard Drugs Found in Spot Checks
- Company Name: Henan Baiyuankang Pharmaceutical Co., Ltd.
- Publication Date: 2017-12-06
- Drug Name: Stir-fried jujube seeds
- Inspection Finding: Moisture content not up to standard
- Action Taken: Seize, impound, and suspend sales of the inspected goods, and investigate and punish the source of the inspected goods in accordance with the law.
- Summary: On December 6, 2017, the Henan Provincial Food and Drug Administration announced findings from recent drug quality assessments, identifying five batches of substandard Traditional Chinese Medicine (TCM) products from three manufacturers. The companies involved were Henan Baiyuankang Pharmaceutical Co., Ltd., Yuzhou Jindi Traditional Chinese Medicine Pieces Co., Ltd., and Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd.Tests conducted by various provincial and municipal drug inspection agencies revealed several quality deficiencies. Henan Baiyuankang Pharmaceutical Co., Ltd. produced Psoralea corylifolia that was generally substandard and Fried Ziziphus jujuba var. spinosa with excessive moisture. Yuzhou Jindi Traditional Chinese Medicine Pieces Co., Ltd.'s Atractylodes lancea failed due to incorrect content. Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd. was cited for Lycium barbarum having excessive moisture and Schisandra chinensis containing impurities.Operating under the oversight of the Henan Provincial Food and Drug Administration, these findings triggered immediate regulatory action. The administration mandated that relevant departments implement risk control measures, including the sealing, seizing, and suspension of sales for all affected batches. Furthermore, thorough investigations and appropriate legal penalties are required for the units responsible for the manufacturing and sourcing of these non-compliant drugs, ensuring public safety and adherence to quality standards.

Company: https://www.globalkeysolutions.net/companies/henan-baiyuankang-pharmaceutical-co-ltd/c2473270-07e8-4abb-ad5c-4474e0f0c45c/